Coraxan (ivabradine)coated tablets 7.5 mg. №56

$58.00

Manufacturer: France

Purpose: Inhibits If current in heart cells, lowers heart rate in angina.

SKU: MED57440 Category:

Description

Coraxan (Ivabradine) Coated Tablets 7.5 mg. №56

Ingredients

Each coated tablet contains 7.5 mg of Ivabradine.

Mechanism of Action

Ivabradine selectively inhibits the If current in the sinoatrial node, leading to a reduction in heart rate without affecting myocardial contractility.

Pharmacological Properties

Coraxan (Ivabradine) acts as a specific inhibitor of the pacemaker If current in the sinoatrial node of the heart, resulting in a decrease in heart rate.

Indications for Use

Coraxan is indicated for the treatment of chronic stable angina pectoris in adults with normal sinus rhythm who cannot tolerate or have inadequate response to beta-blockers.

Contraindications

Avoid using Coraxan if you have severe liver impairment, resting heart rate below 60 beats per minute before treatment, or if you are pregnant or breastfeeding.

Side Effects

Common side effects of Coraxan may include bradycardia, luminous phenomena (phosphenes), and atrial fibrillation.

Usage Instructions

The recommended dosage is one tablet twice daily. Take Coraxan exactly as prescribed by your healthcare provider. Swallow the tablet whole with a glass of water, preferably with food.

Benefits Compared to Analogues

Coraxan has shown significant efficacy in reducing the number of angina attacks and improving exercise tolerance in patients with chronic stable angina compared to traditional beta-blockers.

Suitable Patient Groups

Coraxan is suitable for adult patients with normal sinus rhythm who are unable to tolerate or have an inadequate response to beta-blockers.

Storage and Shelf Life

Store Coraxan in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use if expired.

Packaging Description

Coraxan is available in blister packs containing 56 coated tablets of 7.5 mg each.

Scientific Evidence

Coraxan (Ivabradine) has shown significant efficacy in reducing the number of angina attacks and improving exercise tolerance in patients with chronic stable angina.

Clinical trials have demonstrated that Ivabradine, the active ingredient in Coraxan, selectively inhibits the If current in the sinoatrial node, leading to a reduction in heart rate without affecting myocardial contractility.

Additional Information

It is important to regularly monitor your heart rate while taking Coraxan to ensure it stays within the recommended range. Consult your doctor before starting Coraxan to determine if it is the right treatment option for your condition.